Metabolic Flux and Stable Isotope Tracing

Tracing answers where carbon went; it answers how fast only with rates and a model.

Tracer Selection

QuestionTracerPosition matters because
Is glucose oxidised or exported as lactate?[U-¹³C]glucoseUniform label reports the destination, not the route
Is glutamine oxidised or reductively carboxylated?[1-¹³C]glutamine or [U-¹³C]glutamineC1 loss reports oxidation; retention reports reductive carboxylation
Does pyruvate enter via PDH or PC?[3-¹³C]pyruvate or [1-¹³C]pyruvateDifferent carbons label different products
Is fatty acid oxidation active?[U-¹³C]palmitateLabel dilution by endogenous pools is the issue
Is serine synthesised or imported?[U-¹³C]glucoseReports synthesis; imported serine is unlabelled
Is one-carbon flux going to nucleotides or methylation?[3-¹³C]serineC3 is the one-carbon carrier

Important distinction. Position-specific tracers answer mechanism questions; uniformly labelled tracers answer destination questions. Using a uniform tracer for a mechanism claim is the most common design error in this literature, because several routes produce overlapping isotopologue patterns.

Part 1 — Reading Mitochondrial Patterns

ObservationInterpretationConfounder
Citrate m+2 from [U-¹³C]glucoseOne turn of PDH plus one turn of the cyclePyruvate cycling dilutes label
Citrate m+3 or m+4Pyruvate carboxylation, or multiple turnsPool heterogeneity
Glutamine-derived citrate m+5 in hypoxiaReductive carboxylationCompartment mixing in bulk extracts
Succinate and fumarate labelled asymmetricallyCycle turnover with exchangeReverse flux through SDH
Aspartate m+4 from [U-¹³C]glutamineGlutamine anaplerosis to oxaloacetateTransamination equilibrium
Malate m+3 from [1-¹³C]glucosePyruvate carboxylationShuttle exchange

Readout note. Citrate is the most informative single metabolite in mitochondrial tracing, because it receives acetyl-CoA from several sources. Its isotopologue distribution reports which source dominated, provided the timepoint is short enough that recycling has not flattened the pattern.

Part 2 — From Labelling to Flux

RequirementWhat it meansWithout it
Extracellular ratesSubstrate consumption and product releaseOnly relative routing
A network modelStoichiometry including compartmentationNo flux estimate
Steady-state assumption checkedPools stable over the labelling windowFluxes describe a transient
Isotopologue distribution, not one massFull mass isotopomer distributionConflation of routes
Identifiability assessmentWhether the data constrain the parametersA curve fit presented as a flux
Fit quality reportedResiduals and confidence intervalsPrecision without accuracy

Caveat on "flux analysis" as a label. A paper that reports labelled fractions and calls the result "flux" has reported routing. Formal ¹³C metabolic flux analysis integrates the isotopologue data with extracellular rates and a defined network, and reports a fit. The distinction is not semantic: two routes can produce the same labelled fraction at different fluxes.

Part 3 — Design Choices That Determine the Answer

ChoiceConsequence
Labelling durationShort: routing. Long: recycling and steady state
Tracer concentrationMust be saturating, or the flux depends on supply
Medium compositionCompeting substrates change the partition
Cell densityChanges per-cell rates and oxygen availability
Sampling and quenchingDegradation and re-equilibration artefacts
Compartment inferenceBulk extracts average mitochondrial and cytosolic pools

Important distinction. Tracer concentration is a design variable, not a detail. At subsaturating concentrations, the measured labelling reports the transporter and the medium, not the pathway capacity. Most protocols use saturating concentrations for this reason, but a "physiological concentration" experiment is a different design with a different interpretation.

Part 4 — What Tracing Can and Cannot Support

ClaimSupportedNot supported
"Glucose carbon reached the TCA cycle"Yes, from citrate labellingThe rate at which it did
"Reductive carboxylation occurred"Yes, from citrate m+5 in hypoxiaIts quantitative contribution without a model
"Glutamine is the main anaplerotic substrate"ProvisionallyA fraction of total anaplerosis, without MFA
"Flux through PDH increased"Only with MFA or a PDH-specific designLabelled fraction alone
"The pathway is required"NoAny labelling result

Part 5 — A Worked Design

A concrete example: does a tumour line oxidise glutamine or use it for reductive carboxylation?

ElementChoiceReason
Tracer[U-¹³C]glutamine, with a [1-¹³C]glutamine armC1 loss distinguishes oxidation from reductive use
Timepoints1, 4 and 12 hoursRouting at 1 h; recycling visible by 12 h
Substrate backgroundGlucose present, glutamine at the experimental concentrationCompeting substrates change the partition
OxygenNormoxia and 1% O₂ armsReductive carboxylation is hypoxia-favoured
ReadoutsCitrate, malate, aspartate, 2-HG, palmitateCitrate for route; palmitate for lipogenic use
Extracellular ratesGlutamine consumption, ammonia, lactateNeeded for any absolute claim
ModelCompartmented network with IDH forward and reverseSingle pool cannot represent both directions

The two-tracer design is what makes the claim specific: [U-¹³C]glutamine shows where carbon arrived, and [1-¹³C]glutamine shows whether the first carbon was lost as CO₂. Concordance between the two is the evidence; either alone is a pattern.

The palmitate readout deserves a note: lipogenesis from glutamine is the functional consequence of reductive carboxylation, and it is the readout that a reviewer will look for. It requires enough label incorporation to detect, which is why the 12-hour timepoint is included.

Part 6 — Common Failures

  • • Uniform tracer used for a mechanism claim.
  • • A single timepoint, so recycling cannot be assessed.
  • • One mass isotopologue reported instead of the distribution.
  • • Labelled fraction reported as flux.
  • • Tracer concentration not stated, or subsaturating.
  • • Extracellular rates not measured, precluding absolute flux.
  • • Compartment inferred from bulk data.
  • • Natural abundance not corrected.
  • • MFA reported without an identifiability check.

Part 7 — Where This Article Connects

This is the tracing-principles article of the mitochondrial cluster. The analysis workflow article in this cluster covers the computational steps; the oncometabolite article covers the specific measurements for 2-HG and succinate; and the glucose pillar covers the general isotopologue interpretation that this article applies to mitochondrial questions.

If you need tracing designed around a specific mitochondrial route with extracellular rates and a fit assessment, we can scope the study with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Labelling patterns, pool sizes and route contributions vary with cell type, medium, oxygen tension and labelling duration. The interpretations here are conditional on the design.

An isotopologue pattern identifies routing; it does not establish an absolute flux without extracellular rates and a validated model.

Scientific interpretation and experimental design

  • • Position-specific tracers answer mechanism. Uniform tracers answer destination.
  • • Citrate reports the source. Keep the window short.
  • • Flux needs rates and a model.
  • • Check the steady state.
  • • Report the distribution, not one mass.
  • • Tracer concentration is a variable.

Selected references for further reading

  • • Buescher JM, et al. A roadmap for interpreting ¹³C metabolite labeling patterns from cells. Current Opinion in Biotechnology. 2015;34:189–201.
  • • Antoniewicz MR. A guide to ¹³C metabolic flux analysis for the cancer biologist. Experimental & Molecular Medicine. 2018;50:1–13.
  • • Jang C, et al. Metabolomics and isotope tracing. Cell. 2018;173:822–837.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: